CXCL4
CXCL4, also known as platelet factor 4 (PF4) or SCYB4, is a secreted CXC chemokine released during platelet aggregation. It binds heparin with high affinity and acts on haematopoiesis, angiogenesis, inflammation and T-cell function. Browse Assay Genie's current range of CXCL4 research reagents below, or read on for the biology behind the target.
CXCL4 is a chemokine released from the alpha granules of activated platelets, where it is stored and secreted as a homotetramer. It binds heparin more strongly than it binds the chondroitin-4-sulfate chains of its carrier molecule, and in doing so neutralises the anticoagulant effect of heparin. It also interacts with thrombomodulin to enhance protein C activation, which potentiates the anticoagulant activity of protein C. The protein is therefore involved in both platelet aggregation and the regulation of coagulation.
CXCL4 signals through several receptors, including CCR1, CXCR3A and CXCR3B. Through CCR1 it is chemotactic for neutrophils and monocytes. Through CXCR3A it induces migration of activated T lymphocytes, mediated by downstream Ras/ERK signalling. Together with toll-like receptor 8 (TLR8), it induces chromatin remodelling and activates inflammatory gene expression via the TBK1-IRF5 axis. It also inhibits endothelial cell proliferation, and stimulates myofibroblast differentiation and collagen synthesis in precursor cells, including endothelial cells, by promoting endothelial-to-mesenchymal transition.
In haematopoiesis, CXCL4 inhibits blood cell formation and helps maintain haematopoietic stem cell quiescence. NCBI Gene also describes it as an inhibitor of angiogenesis and T-cell function, and reports antimicrobial activity against Plasmodium falciparum. The PF4 gene encodes the protein, which belongs to the intercrine alpha (chemokine CxC) family. HGNC lists the approved name as platelet factor 4, with SCYB4 and CXCL4 as aliases. Mouse and rat both carry a Pf4 ortholog.
CXCL4 is released during platelet aggregation, binds heparin strongly and enhances protein C activation through thrombomodulin.
CXCL4 inhibits haematopoiesis and contributes to maintaining haematopoietic stem cell quiescence.
CXCL4 attracts neutrophils, monocytes and activated T cells, and drives inflammatory gene expression with TLR8 via TBK1-IRF5.
CXCL4 inhibits endothelial proliferation and promotes endothelial-to-mesenchymal transition, myofibroblast differentiation and collagen synthesis.
CXCL4 is a platelet-derived chemokine that neutralises heparin's anticoagulant effect, attracts neutrophils, monocytes and activated T cells, and inhibits endothelial proliferation and haematopoiesis. It acts through receptors including CCR1, CXCR3A and CXCR3B, and also cooperates with TLR8 to activate inflammatory gene expression.
The gene symbol is PF4, and the protein is called platelet factor 4. SCYB4 and CXCL4 are aliases listed by HGNC. The name CXCL4 reflects its place in the CXC chemokine family, also called the intercrine alpha family.
Yes. Mouse and rat each have an ortholog named Pf4. The source data does not describe differences between species, so check the datasheet of any product for its validated reactivity before using it with a particular species.
Targets with similar gene symbols to PF4, including profilin, phosphofructokinase and prefoldin family members, are listed here. They are not functional partners of CXCL4.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P02776; product specifications from Assay Genie datasheets.